Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

LUMO - Lumos Pharma Inc Stock Price, Fair Value and News

$4.34 
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

LUMO Price Action

Last 7 days

0.2%

Last 30 days

0.9%

Last 90 days

10.4%

Trailing 12 Months

52.3%

LUMO RSI Chart

MarAprMayJunJulAugSepOctNovDec020406080100

LUMO Valuation

Market Cap

37.5M

Price/Earnings (Trailing)

-1.08

Price/Sales (Trailing)

25.26

EV/EBITDA

-0.73

Price/Free Cashflow

-1.19

LUMO Price/Sales (Trailing)

2022202320240100200300400500600

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LUMO Fundamentals

LUMO Revenue

20102012201420162018202020222024050M100M150M200M

LUMO Earnings

2005201020152020-100M-50M050M100M

LUMO Profitability

Free Cashflow Yield

-84.38%

LUMO Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
20102012201420162018202020222024050M100M150M200M
Net sales
YearQ1Q2Q3Q4
20241.5M1.5M00
20232.1M2.2M1.7M2.1M
2022553.3K876.5K1.2M1.5M
20210188.7K209.3K230.0K
2020744.0K552.0K360.0K168.0K
20199.6M6.7M3.8M936.0K
201835.9M27.7M22.4M12.5M
201732.8M41.2M31.3M28.7M
201635.0M29.6M30.7M35.8M
2015191.8M210.9M230.1M68.5M
20141.1M1.1M86.8M172.6M
20131.5M1.2M1.1M1.1M
20121.7M1.8M1.7M1.7M
20112.0M2.0M1.9M1.9M
2010001.5M2.1M
2009000934.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Lumos Pharma Inc

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.
 CEO
 WEBSITEhttps://lumos-pharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES32

Lumos Pharma Inc Frequently Asked Questions

What is the ticker symbol for Lumos Pharma Inc? What does LUMO stand for in stocks?

LUMO is the stock ticker symbol of Lumos Pharma Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lumos Pharma Inc (LUMO)?

As of Fri Dec 13 2024, market cap of Lumos Pharma Inc is 37.54 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LUMO stock?

You can check LUMO's fair value in chart for subscribers.

Is Lumos Pharma Inc a good stock to buy?

The fair value guage provides a quick view whether LUMO is over valued or under valued. Whether Lumos Pharma Inc is cheap or expensive depends on the assumptions which impact Lumos Pharma Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LUMO.

What is Lumos Pharma Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 13 2024, LUMO's PE ratio (Price to Earnings) is -1.08 and Price to Sales (PS) ratio is 25.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LUMO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Lumos Pharma Inc's stock?

In the past 10 years, Lumos Pharma Inc has provided -0.184 (multiply by 100 for percentage) rate of return.